Author:
Lazzerini Marzia,Sforzi Idanna,Trapani Sandra,Biban Paolo,Silvagni Davide,Mariani Ilaria,Villa Giovanna,Tibaldi Jessica,Bertacca Luca,Felici Enrico,Perricone Giuseppina,Parrino Roberta,Gioè Claudia,Lega Sara,Conte Mariasole,Marchetti Federico,Magista Annamaria,Berlese Paola,Martelossi Stefano,Vaienti Francesca,Valletta Enrico,Mauro Margherita,Dall’Amico Roberto,Fasoli Silvia,Gatto Antonio,Chiaretti Antonio,Dragovic Danica,Pascolo Paola,Pilotto Chiara,Liguoro Ilaria,Miorin Elisabetta,Saretta Francesca,Trobia Gianluca,Stefano Antonella Di,Orlandi Azzurra,Cardinale Fabio,Lubrano Riccardo,Testa Alessia,Binotti Marco,Moressa Valentina,Barbi Egidio,Armocida Benedetta
Abstract
ABSTRACTBackgroundNo study has described factors associated with COVID-19 diagnosis in children.AimDescribe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 pediatric centers across Italy.MethodsCases aged 0-18 years tested for SARS-CoV-2 between February 23 and May 24 2020 were included. Our primary analysis focused on children tested because of COVID-19 suggestive symptoms.ResultsAmong 2494 children tested for SARS-CoV-2, 2148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of SARS-CoV-2 included - beside fever (82.4%) and respiratory signs or symptoms (60.4%) – also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other flu-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARS-CoV-2 were: exposure history (adjusted OR 39.83 95%CI 17.52-90.55 p<0.0001), cardiac disease (adjusted OR 3.10 95%CI 1.19-5.02 p<0.0001), fever (adjusted OR 3.05 % 95% CI 1.67-5.58 p=0.0003), and anosmia/ageusia (OR 4.08 95%CI 1.69 −9.84 p=0.002). Among 190 (7.6%) children diagnosed with SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted in ICU, while 100% recovered.ConclusionRecommendations for SARS-CoV-2 testing in children should be updated based on the evidence of broader clinical features. Exposure history, fever, and anosmia/ageusia are strong risk factors for COVID-19 in children, while other symptoms don’t seem helping discriminating in between the SARS-CoV-2 positive and the negative cases. This study confirm that COVID-19 is a mild disease in the general population of children in Italy. Further studies are needed to understand the risk, clinical spectrum and outcomes of COVID-19 in children with specific preexisting conditions.
Publisher
Cold Spring Harbor Laboratory
Reference45 articles.
1. World Health Organization. Coronavirus disease (COVID-2019) situation reports 79. Available at (accessed on March 27, 2020) https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
2. COVID-19. Situation in Italy. Available on http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5351&area=nuovoCoronavirus&menu=vuoto (accessed May 28, 2020)
3. Ministero della Salute. COVID-19, i casi in Italia 24 maggio 2020. Aggiornamento nazionale 24 maggio 2020. Avallabile at http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4807 (accessed September 29, 2020)
4. Dong Y , Mo X , Hu Y , Qi X , Jiang F , Jiang Z , et al. Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China. Pediatrics. 2020 Mar 16
5. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks